Journalists & Patients Banned from ESMO Rx Drug Discussions | Pharmaguy's Insights Into Drug Industry News |

ESMO shares the disappointment of journalists, patient advocates and other non-prescribers for not being admitted to areas and activities where the promotion of prescription-only medicinal products takes place.

As an organisation working to disseminate knowledge in oncology, we would like to be able to offer every congress attendee full access to knowledge-sharing opportunities, which forms the foundation of our Congress philosophy.

As a respected organisation working with various oncology stakeholders, we have to abide by the regulations in the country where the Congress is being held, in this case Spain. ESMO has been legally advised that a Spanish national law (based on a 2001 EU Regulation) related to non-prescribers applies to medical congresses organised in Spain and we need to be  compliant with it .

The following individuals may not access the spaces of the ESMO Congress where promotion of prescription-only or funded medicinal products or medical devices takes place:

  • Patients
  • Patient advocates
  • Students
  • Nurses
  • Journalists